Overview
Eric Dedeke is a Public Health and Preventive Medicine provider in Oklahoma City, Oklahoma. His top area of expertise is ALK-Positive Non-Small Cell Lung Cancer. Dr. Dedeke is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
3400 Nw Expressway, Suite 500, Oklahoma City, OK 73112
Integris Ambulatory Care Corporation
Brad Liston is a Family Medicine provider in Oklahoma City, Oklahoma. Dr. Liston is highly rated in 16 conditions, according to our data. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Hypertension, and Familial Hypertension. Dr. Liston is currently accepting new patients.
Integris Ambulatory Care Corporation
Aaron Wilcox is a Family Medicine provider in Oklahoma City, Oklahoma. Dr. Wilcox is highly rated in 30 conditions, according to our data. His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Urinary Tract Infection in Children. Dr. Wilcox is currently accepting new patients.
Saints Medical Group, LLC
David Dye is a Family Medicine provider in Oklahoma City, Oklahoma. Dr. Dye is highly rated in 75 conditions, according to our data. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Type 2 Diabetes (T2D). Dr. Dye is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Dedeke isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.